Global Contraceptives Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

Publisher Name :
Date: 08-Jan-2020
No. of pages: 100

Summary

Market Overview

The global Contraceptives market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.4% in the forecast period of 2020 to 2025 and will expected to reach USD 2056.1 million by 2025, from USD 1872.7 million in 2019.

The Contraceptives market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Contraceptives market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Contraceptives market has been segmented into Prolonged Contraception, Short-term Contraception, Emergency Contraception, etc.

By Application, Contraceptives has been segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Contraceptives market presented in the report. This section sheds light on the sales growth of different regional and country-level Contraceptives markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Contraceptives market.

The report offers in-depth assessment of the growth and other aspects of the Contraceptives market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Contraceptives markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.

Competitive Landscape and Contraceptives Market Share Analysis

Contraceptives competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Contraceptives sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Contraceptives sales, revenue and market share for each player covered in this report.

The major players covered in Contraceptives are: Bayer AG, Novo Nordisk A/S, Merck & Co., Inc, Pfizer, Inc, Gedeon Richter, Teva Pharmaceutical Industries Ltd, Baijingyu, Johnson & Johnson, Actavis, Inc., ZiZhu, Huazhong, Sine, etc. Among other players domestic and global, Contraceptives market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Contraceptives product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Contraceptives, with price, sales, revenue and global market share of Contraceptives in 2018 and 2019.

Chapter 3, the Contraceptives competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Contraceptives breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.

Chapter 12, Contraceptives market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.

Chapter 13, 14 and 15, to describe Contraceptives sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Global Contraceptives Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

Table of Contents

1 Market Overview
1.1 Contraceptives Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Contraceptives Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Prolonged Contraception
1.2.3 Short-term Contraception
1.2.4 Emergency Contraception
1.3 Market Analysis by Application
1.3.1 Overview: Global Contraceptives Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Overview of Global Contraceptives Market
1.4.1 Global Contraceptives Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer AG
2.1.1 Bayer AG Details
2.1.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bayer AG SWOT Analysis
2.1.4 Bayer AG Product and Services
2.1.5 Bayer AG Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novo Nordisk A/S
2.2.1 Novo Nordisk A/S Details
2.2.2 Novo Nordisk A/S Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novo Nordisk A/S SWOT Analysis
2.2.4 Novo Nordisk A/S Product and Services
2.2.5 Novo Nordisk A/S Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck & Co., Inc
2.3.1 Merck & Co., Inc Details
2.3.2 Merck & Co., Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck & Co., Inc SWOT Analysis
2.3.4 Merck & Co., Inc Product and Services
2.3.5 Merck & Co., Inc Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer, Inc
2.4.1 Pfizer, Inc Details
2.4.2 Pfizer, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer, Inc SWOT Analysis
2.4.4 Pfizer, Inc Product and Services
2.4.5 Pfizer, Inc Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Gedeon Richter
2.5.1 Gedeon Richter Details
2.5.2 Gedeon Richter Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Gedeon Richter SWOT Analysis
2.5.4 Gedeon Richter Product and Services
2.5.5 Gedeon Richter Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Teva Pharmaceutical Industries Ltd
2.6.1 Teva Pharmaceutical Industries Ltd Details
2.6.2 Teva Pharmaceutical Industries Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Teva Pharmaceutical Industries Ltd SWOT Analysis
2.6.4 Teva Pharmaceutical Industries Ltd Product and Services
2.6.5 Teva Pharmaceutical Industries Ltd Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Baijingyu
2.7.1 Baijingyu Details
2.7.2 Baijingyu Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Baijingyu SWOT Analysis
2.7.4 Baijingyu Product and Services
2.7.5 Baijingyu Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Johnson & Johnson SWOT Analysis
2.8.4 Johnson & Johnson Product and Services
2.8.5 Johnson & Johnson Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Actavis, Inc.
2.9.1 Actavis, Inc. Details
2.9.2 Actavis, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Actavis, Inc. SWOT Analysis
2.9.4 Actavis, Inc. Product and Services
2.9.5 Actavis, Inc. Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 ZiZhu
2.10.1 ZiZhu Details
2.10.2 ZiZhu Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 ZiZhu SWOT Analysis
2.10.4 ZiZhu Product and Services
2.10.5 ZiZhu Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Huazhong
2.11.1 Huazhong Details
2.11.2 Huazhong Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Huazhong SWOT Analysis
2.11.4 Huazhong Product and Services
2.11.5 Huazhong Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Sine
2.12.1 Sine Details
2.12.2 Sine Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Sine SWOT Analysis
2.12.4 Sine Product and Services
2.12.5 Sine Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Contraceptives Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Contraceptives Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Contraceptives Manufacturer Market Share in 2019
3.3.2 Top 6 Contraceptives Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Contraceptives Sales, Revenue and Market Share by Regions
4.1.1 Global Contraceptives Sales and Market Share by Regions (2015-2020)
4.1.2 Global Contraceptives Revenue and Market Share by Regions (2015-2020)
4.2 North America Contraceptives Sales and Growth Rate (2015-2020)
4.3 Europe Contraceptives Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Contraceptives Sales and Growth Rate (2015-2020)
4.5 South America Contraceptives Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Contraceptives Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Contraceptives Sales, Revenue and Market Share by Country
5.1.1 North America Contraceptives Sales and Market Share by Country (2015-2020)
5.1.2 North America Contraceptives Revenue and Market Share by Country (2015-2020)
5.2 United States Contraceptives Sales and Growth Rate (2015-2020)
5.3 Canada Contraceptives Sales and Growth Rate (2015-2020)
5.4 Mexico Contraceptives Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Contraceptives Sales, Revenue and Market Share by Country
6.1.1 Europe Contraceptives Sales and Market Share by Country (2015-2020)
6.1.2 Europe Contraceptives Revenue and Market Share by Country (2015-2020)
6.2 Germany Contraceptives Sales and Growth Rate (2015-2020)
6.3 UK Contraceptives Sales and Growth Rate (2015-2020)
6.4 France Contraceptives Sales and Growth Rate (2015-2020)
6.5 Russia Contraceptives Sales and Growth Rate (2015-2020)
6.6 Italy Contraceptives Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Contraceptives Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Contraceptives Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Contraceptives Revenue and Market Share by Regions (2015-2020)
7.2 China Contraceptives Sales and Growth Rate (2015-2020)
7.3 Japan Contraceptives Sales and Growth Rate (2015-2020)
7.4 Korea Contraceptives Sales and Growth Rate (2015-2020)
7.5 India Contraceptives Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Contraceptives Sales and Growth Rate (2015-2020)
7.7 Australia Contraceptives Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Contraceptives Sales, Revenue and Market Share by Country
8.1.1 South America Contraceptives Sales and Market Share by Country (2015-2020)
8.1.2 South America Contraceptives Revenue and Market Share by Country (2015-2020)
8.2 Brazil Contraceptives Sales and Growth Rate (2015-2020)
8.3 Argentina Contraceptives Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Contraceptives Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Contraceptives Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Contraceptives Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Contraceptives Sales and Growth Rate (2015-2020)
9.3 Turkey Contraceptives Sales and Growth Rate (2015-2020)
9.4 Egypt Contraceptives Sales and Growth Rate (2015-2020)
9.5 South Africa Contraceptives Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Contraceptives Sales and Market Share by Type (2015-2020)
10.2 Global Contraceptives Revenue and Market Share by Type (2015-2020)
10.3 Global Contraceptives Price by Type (2015-2020)
11 Global Contraceptives Market Segment by Application
11.1 Global Contraceptives Sales Market Share by Application (2015-2020)
11.2 Global Contraceptives Revenue Market Share by Application (2015-2020)
11.3 Global Contraceptives Price by Application (2015-2020)
12 Market Forecast
12.1 Global Contraceptives Sales, Revenue and Growth Rate (2021-2025)
12.2 Contraceptives Market Forecast by Regions (2021-2025)
12.2.1 North America Contraceptives Market Forecast (2021-2025)
12.2.2 Europe Contraceptives Market Forecast (2021-2025)
12.2.3 Asia-Pacific Contraceptives Market Forecast (2021-2025)
12.2.4 South America Contraceptives Market Forecast (2021-2025)
12.2.5 Middle East & Africa Contraceptives Market Forecast (2021-2025)
12.3 Contraceptives Market Forecast by Type (2021-2025)
12.3.1 Global Contraceptives Sales Forecast by Type (2021-2025)
12.3.2 Global Contraceptives Market Share Forecast by Type (2021-2025)
12.4 Contraceptives Market Forecast by Application (2021-2025)
12.4.1 Global Contraceptives Sales Forecast by Application (2021-2025)
12.4.2 Global Contraceptives Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Contraceptives Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Contraceptives by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Contraceptives Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 8. Bayer AG Contraceptives Major Business
Table 9. Bayer AG Contraceptives Total Revenue (USD Million) (2017-2018)
Table 10. Bayer AG SWOT Analysis
Table 11. Bayer AG Contraceptives Product and Services
Table 12. Bayer AG Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 14. Novo Nordisk A/S Contraceptives Major Business
Table 15. Novo Nordisk A/S Contraceptives Total Revenue (USD Million) (2017-2018)
Table 16. Novo Nordisk A/S SWOT Analysis
Table 17. Novo Nordisk A/S Contraceptives Product and Services
Table 18. Novo Nordisk A/S Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 20. Merck & Co., Inc Contraceptives Major Business
Table 21. Merck & Co., Inc Contraceptives Total Revenue (USD Million) (2017-2018)
Table 22. Merck & Co., Inc SWOT Analysis
Table 23. Merck & Co., Inc Contraceptives Product and Services
Table 24. Merck & Co., Inc Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Pfizer, Inc Basic Information, Manufacturing Base and Competitors
Table 26. Pfizer, Inc Contraceptives Major Business
Table 27. Pfizer, Inc Contraceptives Total Revenue (USD Million) (2017-2018)
Table 28. Pfizer, Inc SWOT Analysis
Table 29. Pfizer, Inc Contraceptives Product and Services
Table 30. Pfizer, Inc Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Gedeon Richter Basic Information, Manufacturing Base and Competitors
Table 32. Gedeon Richter Contraceptives Major Business
Table 33. Gedeon Richter Contraceptives Total Revenue (USD Million) (2017-2018)
Table 34. Gedeon Richter SWOT Analysis
Table 35. Gedeon Richter Contraceptives Product and Services
Table 36. Gedeon Richter Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 38. Teva Pharmaceutical Industries Ltd Contraceptives Major Business
Table 39. Teva Pharmaceutical Industries Ltd Contraceptives Total Revenue (USD Million) (2017-2018)
Table 40. Teva Pharmaceutical Industries Ltd SWOT Analysis
Table 41. Teva Pharmaceutical Industries Ltd Contraceptives Product and Services
Table 42. Teva Pharmaceutical Industries Ltd Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Baijingyu Basic Information, Manufacturing Base and Competitors
Table 44. Baijingyu Contraceptives Major Business
Table 45. Baijingyu Contraceptives Total Revenue (USD Million) (2017-2018)
Table 46. Baijingyu SWOT Analysis
Table 47. Baijingyu Contraceptives Product and Services
Table 48. Baijingyu Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 50. Johnson & Johnson Contraceptives Major Business
Table 51. Johnson & Johnson Contraceptives Total Revenue (USD Million) (2017-2018)
Table 52. Johnson & Johnson SWOT Analysis
Table 53. Johnson & Johnson Contraceptives Product and Services
Table 54. Johnson & Johnson Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Actavis, Inc. Basic Information, Manufacturing Base and Competitors
Table 56. Actavis, Inc. Contraceptives Major Business
Table 57. Actavis, Inc. Contraceptives Total Revenue (USD Million) (2017-2018)
Table 58. Actavis, Inc. SWOT Analysis
Table 59. Actavis, Inc. Contraceptives Product and Services
Table 60. Actavis, Inc. Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. ZiZhu Basic Information, Manufacturing Base and Competitors
Table 62. ZiZhu Contraceptives Major Business
Table 63. ZiZhu Contraceptives Total Revenue (USD Million) (2017-2018)
Table 64. ZiZhu SWOT Analysis
Table 65. ZiZhu Contraceptives Product and Services
Table 66. ZiZhu Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Huazhong Basic Information, Manufacturing Base and Competitors
Table 68. Huazhong Contraceptives Major Business
Table 69. Huazhong Contraceptives Total Revenue (USD Million) (2017-2018)
Table 70. Huazhong SWOT Analysis
Table 71. Huazhong Contraceptives Product and Services
Table 72. Huazhong Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Sine Basic Information, Manufacturing Base and Competitors
Table 74. Sine Contraceptives Major Business
Table 75. Sine Contraceptives Total Revenue (USD Million) (2017-2018)
Table 76. Sine SWOT Analysis
Table 77. Sine Contraceptives Product and Services
Table 78. Sine Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Global Contraceptives Sales by Manufacturer (2018-2019) (MT)
Table 80. Global Contraceptives Revenue by Manufacturer (2018-2019) (USD Million)
Table 81. Global Contraceptives Sales by Regions (2015-2020) (MT)
Table 82. Global Contraceptives Sales Market Share by Regions (2015-2020)
Table 83. Global Contraceptives Revenue by Regions (2015-2020) (USD Million)
Table 84. North America Contraceptives Sales by Countries (2015-2020) (MT)
Table 85. North America Contraceptives Sales Market Share by Countries (2015-2020)
Table 86. North America Contraceptives Revenue by Countries (2015-2020) (USD Million)
Table 87. North America Contraceptives Revenue Market Share by Countries (2015-2020)
Table 88. Europe Contraceptives Sales by Countries (2015-2020) (MT)
Table 89. Europe Contraceptives Sales Market Share by Countries (2015-2020)
Table 90. Europe Contraceptives Revenue by Countries (2015-2020) (USD Million)
Table 91. Asia-Pacific Contraceptives Sales by Regions (2015-2020) (MT)
Table 92. Asia-Pacific Contraceptives Sales Market Share by Regions (2015-2020)
Table 93. Asia-Pacific Contraceptives Revenue by Regions (2015-2020) (USD Million)
Table 94. South America Contraceptives Sales by Countries (2015-2020) (MT)
Table 95. South America Contraceptives Sales Market Share by Countries (2015-2020)
Table 96. South America Contraceptives Revenue by Countries (2015-2020) (USD Million)
Table 97. South America Contraceptives Revenue Market Share by Countries (2015-2020)
Table 98. Middle East & Africa Contraceptives Sales by Countries (2015-2020) (MT)
Table 99. Middle East & Africa Contraceptives Sales Market Share by Countries (2015-2020)
Table 100. Middle East & Africa Contraceptives Revenue by Countries (2015-2020) (USD Million)
Table 101. Middle East & Africa Contraceptives Revenue Market Share by Countries (2015-2020)
Table 102. Global Contraceptives Sales by Type (2015-2020) (MT)
Table 103. Global Contraceptives Sales Share by Type (2015-2020)
Table 104. Global Contraceptives Revenue by Type (2015-2020) (USD Million)
Table 105. Global Contraceptives Revenue Share by Type (2015-2020)
Table 106. Global Contraceptives Sales by Application (2015-2020) (MT)
Table 107. Global Contraceptives Sales Share by Application (2015-2020)
Table 108. Global Contraceptives Sales Forecast by Regions (2021-2025) (MT)
Table 109. Global Contraceptives Market Share Forecast by Regions (2021-2025)
Table 110. Global Contraceptives Sales Forecast by Type (2021-2025) (MT)
Table 111. Global Contraceptives Market Share Forecast by Type (2021-2025)
Table 112. Global Contraceptives Sales Forecast by Application (2021-2025)
Table 113. Global Contraceptives Market Share Forecast by Application (2021-2025)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Distributors/Traders/ Dealers List

List of Figures

Figure 1. Contraceptives Picture
Figure 2. Global Sales Market Share of Contraceptives by Type in 2019
Figure 3. Prolonged Contraception Picture
Figure 4. Short-term Contraception Picture
Figure 5. Emergency Contraception Picture
Figure 6. Contraceptives Sales Market Share by Application in 2018
Figure 7. Hospital Pharmacies Picture
Figure 8. Retail Pharmacies Picture
Figure 9. Online Pharmacies Picture
Figure 10. Others Picture
Figure 11. Global Contraceptives Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Contraceptives Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Contraceptives Sales Market Share by Manufacturer in 2019
Figure 32. Global Contraceptives Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Contraceptives Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Contraceptives Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 37. Global Contraceptives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Contraceptives Revenue Market Share by Regions (2015-2020)
Figure 39. Global Contraceptives Revenue Market Share by Regions in 2018
Figure 40. North America Contraceptives Sales and Growth Rate (2015-2020)
Figure 41. Europe Contraceptives Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Contraceptives Sales and Growth Rate (2015-2020)
Figure 43. South America Contraceptives Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Contraceptives Sales and Growth Rate (2015-2020)
Figure 45. North America Contraceptives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Contraceptives Sales Market Share by Countries (2015-2020)
Figure 47. North America Contraceptives Sales Market Share by Countries in 2018
Figure 48. North America Contraceptives Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Contraceptives Revenue Market Share by Countries in 2018
Figure 50. United States Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 51. Canada Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 52. Mexico Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 53. Europe Contraceptives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Contraceptives Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Contraceptives Revenue Market Share by Countries in 2019
Figure 56. Germany Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 57. UK Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 58. France Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 59. Russia Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 60. Italy Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 61. Asia-Pacific Contraceptives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Contraceptives Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Contraceptives Revenue Market Share by Regions 2019
Figure 64. China Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 65. Japan Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 66. Korea Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 67. India Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 68. Southeast Asia Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 69. South America Contraceptives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Contraceptives Sales Market Share by Countries in 2019
Figure 71. South America Contraceptives Revenue Market Share by Countries in 2019
Figure 72. Brazil Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 73. Argentina Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 74. Middle East and Africa Contraceptives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Contraceptives Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Contraceptives Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Contraceptives Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 79. Egypt Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 80. Turkey Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 81. South Africa Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 82. Global Contraceptives Sales and Growth Rate (2021-2025) (MT)
Figure 83. Global Contraceptives Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Contraceptives Market Forecast (2021-2025) (MT)
Figure 85. Europe Sales Contraceptives Market Forecast (2021-2025) (MT)
Figure 86. Asia-Pacific Sales Contraceptives Market Forecast (2021-2025) (MT)
Figure 87. South America Sales Contraceptives Market Forecast (2021-2025) (MT)
Figure 88. Middle East & Africa Sales Contraceptives Market Forecast (2021-2025) (MT)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
  • Global Contraceptives Market Growth 2020-2025
    Published: 25-Feb-2020        Price: US 3660 Onwards        Pages: 159
    According to this study, over the next five years the Contraceptives market will register a 2.6% CAGR in terms of revenue, the global market size will reach $ 1970 million by 2025, from $ 1780.4 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Contraceptives business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Contraceptives market by type, applic......
  • Global Postmenopausal Vaginal Atrophy Treatment Market Analysis 2015-2019 and Forecast 2020-2025
    Published: 20-Feb-2020        Price: US 2980 Onwards        Pages: 78
    Snapshot Vaginal atrophy, also known as urogenital atrophy or atrophic vaginitis, is the inflammation of the vagina. It is the result of the vaginal tissues getting shrunken and thinned out. The most common cause of vaginal atrophy is the lack of estrogen, the female reproductive hormone. Vaginal atrophy can be caused during perimenopause and can get aggravated in the postmenopausal phase. The global Postmenopausal Vaginal Atrophy Treatment market size is estimated at xxx m......
  • Global Topical Contraceptive Market Data Survey Report 2015-2025
    Published: 19-Feb-2020        Price: US 1500 Onwards        Pages: 79
    Summary The global Topical Contraceptive market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major End-Use Global market size by Major Type Key manufacturers are included based on company profil......
  • Global Bacterial Vaginosis Drug Market Growth 2020-2025
    Published: 18-Feb-2020        Price: US 3660 Onwards        Pages: 166
    According to this study, over the next five years the Bacterial Vaginosis Drug market will register a 3.3% CAGR in terms of revenue, the global market size will reach $ 956.9 million by 2025, from $ 839.7 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Bacterial Vaginosis Drug business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Bacterial Vaginos......
  • Global Human Chorionic Gonadotropin Market 2020 by Company, Regions, Type and Application, Forecast to 2025
    Published: 18-Feb-2020        Price: US 3480 Onwards        Pages: 108
    Market Overview The global Human Chorionic Gonadotropin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.1% in the forecast period of 2020 to 2025 and will expected to reach USD 789.6 million by 2025, from USD 671.8 million in 2019. The Human Chorionic Gonadotropin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitiv......
  • Topical Contraceptives Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 08-Feb-2020        Price: US 3000 Onwards        Pages: 142
    Topical Contraceptives Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Topical Contraceptives industry with a focus on the Chinese market. The report provides key statistics on the market status of the Topical Contraceptives manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chine......
  • Global Postmenopausal Vaginal Atrophy Treatment Market Data Survey Report 2015-2025
    Published: 07-Feb-2020        Price: US 1500 Onwards        Pages: 64
    Summary Vaginal atrophy, also known as urogenital atrophy or atrophic vaginitis, is the inflammation of the vagina. It is the result of the vaginal tissues getting shrunken and thinned out. The most common cause of vaginal atrophy is the lack of estrogen, the female reproductive hormone. Vaginal atrophy can be caused during perimenopause and can get aggravated in the postmenopausal phase. The global Postmenopausal Vaginal Atrophy Treatment market will reach xxx Million USD ......
  • Drugs for Chlamydia Trachomatis Infection Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 06-Feb-2020        Price: US 3000 Onwards        Pages: 140
    Drugs for Chlamydia Trachomatis Infection Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Drugs for Chlamydia Trachomatis Infection industry with a focus on the Chinese market. The report provides key statistics on the market status of the Drugs for Chlamydia Trachomatis Infection manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report......
  • Bacterial Vaginosis Drug Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 06-Feb-2020        Price: US 3000 Onwards        Pages: 136
    Bacterial Vaginosis Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Bacterial Vaginosis Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Bacterial Vaginosis Drug manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs